big-h3 is a transforming growth factor-b (TGF-b)-induced cell-adhesive molecule and has an RGD sequence at its Cterminus. A previous report suggested that big-h3 normally undergoes carboxy-terminal processing that results in the loss of the RGD sequence. RGD peptides appear to play various roles in cell function. Here we show that the RGD peptides released from big-h3 may facilitate TGF-b-induced apoptosis. We found that carboxy-terminal cleavage of big-h3 occurred after its secretion, and that overexpression of the wild-type big-h3 induced apoptosis, unlike the C-terminal deleted but RGDcontaining mutant big-h3, which is resistant to C-terminal processing. The big-h3-induced apoptosis was abolished by either deletion of the RGD sequence or mutation of RGD to RAE. Synthetic peptides of ERGDEL and GRGDSP derived from big-h3 and fibronectin, respectively, also induced apoptosis, unlike ERGEEL and GRGESP. Culture supernatants of cells overexpressing big-h3 filtered to isolate molecules smaller than 3 kDa also induced apoptosis. A fusion protein composed of the N-terminal 100 amino acids of fibronectin and the RGDcontaining C-terminal part of big-h3 was also subjected to C-terminal cleavage and overexpression resulted in apoptosis. The anti-big-h3 antibody blocks TGF-binduced apoptosis. Thus, big-h3 may be important in regulating cell apoptosis by providing soluble RGD peptides.
Introduction big-h3 is an extracellular matrix protein whose expression in several cell types, including human melanoma cells, mammary epithelial cells, keratinocytes, lung fibroblasts, and bone marrow stromal cells, can be induced by transforming growth factor-b (TGF-b) (Skonier et al., 1994; Dieudonne et al., 1999) . The protein contains an RGD motif and four internal repeat domains that have highly conserved sequences also found in various secretory and membrane proteins from several species, including mammals, insects, sea urchins, plants, yeast, and bacteria (Kawamoto et al., 1998) . A number of studies have suggested that big-h3 is involved in cell growth (Skonier et al., 1994) , cell differentiation (Dieudonne et al., 1999; Kim et al., 2000a) , wound healing (Rawe et al., 1997) , and cell adhesion (LeBaron et al., 1995; Ohno et al., 1999) . Although the underlying mechanisms driving these effects have not been defined, we recently reported that big-h3 may mediate cell adhesion by interacting with the a3b1 integrin through two motifs residing within the 2nd and 4th repeat domains (Kim et al., 2000b) .
It has been reported that transfecting big-h3-expressing plasmids into Chinese hamster ovary (CHO) cells led to a marked decrease in cell growth and a reduction in the ability of these cells to form tumors in nude mice (Skonier et al., 1994) . The same group reported that the recombinant big-h3 expressed in the CHO cells did not retain its RGD sequence, an observation confirmed by carboxy-terminal sequencing. It was suggested that the loss was most likely because of carboxy-terminal processing. The RGD sequence was first discovered in fibronectin (FN) (Pierschbacher and Ruoslahti, 1984) and turned out to be a cell-attaching site found in many other adhesive proteins as well (Ruoslahti, 1996) . The subsequent discovery of integrins, cell surface receptors that recognize the RGD sequence of various proteins, indicates that RGD plays a central role in cell adhesion biology. As integrin-mediated cell attachment influences and regulates cell migration, growth, differentiation, and apoptosis, RGD peptides and mimics have been used as probes to study such cell functions (Ruoslahti, 1996) .
Whether endogenous soluble RGD-containing peptides released from matrix proteins are involved in the above-mentioned cellular functions is as yet not clear. With regard to apoptosis, however, soluble RGD peptides are known to induce a form of apoptosis denoted as 'anoikis'. Here, the RGD peptides compete with the cells for the extracellular matrix, thereby preventing the cells from adhering to the extracellular matrix and inducing them to apoptose (Frisch and Francis, 1994) . A recent paper (Buckley et al., 1999) has also presented evidence for an alternative mechanism by which the RGD peptides facilitate apoptosis as they showed that a soluble RGD peptide directly activates a caspase in the cell cytoplasm. Supporting the putative role for RGD peptides in apoptosis, we have found that overexpressing the wild-type (WT) RGD-containing big-h3 protein in CHO cells yields very few stable transfectants, whereas the overexpression of a mutant form whose RGD-containing C-terminal fragment does not get cleaved off yields many stable transfectants. Based on these preliminary observations, we hypothesize that the RGD peptide released from big-h3 by carboxy-terminal processing might induce apoptosis. In this study, we show that big-h3 indeed induces apoptosis by releasing RGD peptides.
Results

C-terminal cleavage of big-h3 occurs after secretion
The expression plasmids encoding the wild-type big-h3 (pMycb-WT) and a mutant big-h3 lacking its C-terminal 30 amino acids (pMycb-DC30) are illustrated in Figure 1a . pMycb-DC30 was constructed in the process of experiments on big-h3 and unexpectedly, we found the following interesting result. Both plasmids express a protein with an Myc at its C-terminus. When transiently expressed in CHO cells, the pMycb-DC30 protein, but not the pMycb-WT protein, could be detected in the culture supernatant using the anti-myc antibody (Figure 1b) . When the same samples were immunoblotted with the anti-big-h3 antibody, both proteins were detected but the size and quantity of pMycb-WT was less than that of pMycb-DC30 (Figure 1c) . In a parallel experiment, the culture supernatant from H1299 human lung carcinoma cells treated with TGF-b for 24 h was analysed on the same gel ( Figure 1c ). The size of the endogenous big-h3 protein induced by TGF-b treatment was the same as that of pMycb-WT. Thus, the WT bigh3 undergoes C-terminal cleavage, which is consistent with the previously described observations (Skonier et al., 1994) . Furthermore, the lack of its C-terminal 30 amino acids prevents it from being cleaved.
To determine whether WT big-h3 cleavage occurs before or after secretion, we employed monensin to block protein secretion in CHO cells expressing the WT or deletion mutant big-h3 proteins. When we used the anti-big-h3 antibody, we detected proteins in the culture supernatants of both the monensin-treated and -untreated cells. Although monensin inhibited protein secretion but we could still detect big-h3 in the culture supernatant of monensin-treated cultures. However, proteins were detected in the cell layer only after monensin treatment (Figure 1d ) as the untreated cells did not contain detectable levels of the big-h3 protein (data not shown). The pMycb-DC30 protein in the cell layer is slightly bigger than that in the culture supernatant. This was expected because big-h3 is a secretory protein and has a signal peptide at its N-terminus that is retained in the cellular protein but not in the secreted protein. However, the WT big-h3 in the cell layer is much bigger than either the WT big-h3 or pMycb-DC30 in the culture supernatant. These observations suggest that the cleavage of big-h3 occurs following secretion.
The C-terminal fragment cleaved off the pMycb-WT protein should include two epitopes, Myc and His, and is expected to be about 7 kDa. If this fragment is intact after being cleaved, it will be detectable after high percent gel electrophoresis of the cell supernatant. We used antibodies to both the Myc and His epitopes but failed to detect the fragment. This suggests that the fragment may undergo further digestion that results in smaller peptide fragments. Taken together, these results indicate that the C-terminal cleavage of big-h3 occurs after it is secreted, resulting in the release of peptides.
Overexpression of big-h3 induces apoptosis
Overexpression of big-h3 is known to inhibit cell growth and thus we first investigated whether overexpressing big-h3 induces apoptosis. We transiently transfected CHO and H1299 cells with the expression plasmids pMycb-WT and pMycb-DC30. A nucleosomal ladder appeared in the pMycb-WT-transfected CHO and H1299 cells. In contrast, no DNA laddering was detected in cells transfected with either the vector or pMycb-DC30 (Figure 2 ). That cells expressing WT bigh3 undergo apoptosis was confirmed by propidium iodide staining. Furthermore, chromatin condensation and fragmented nuclei were observed in pMycb-WT-transfected CHO and H1299 cells, but not in cells transfected with either the vector or pMycb-DC30 (Figure 3 ). The big-h3-mediated apoptosis was not confined to these two cell lines as it also induced The RGD motif of big-h3 is necessary for big-h3-mediated apoptosis We hypothesized that the RGD motif might play a key role in big-h3-mediated apoptosis and tested this by generating two additional big-h3 expression constructs (Figure 4a ). pMycb-DC44 expresses the big-h3 protein lacking the C-terminal 44 amino acids, including the RGD motif, while pMycb-RAE expresses the big-h3 protein whose RGD motif has been mutated to RAE. That both mutants were expressed was confirmed by immunoblotting with the big-h3 antibody (Figure 4b(b) ). pMycb-WT and pMycb-RAE were not detected by the anti-myc antibody because of the C-terminal cleavage (Figure 4b(a) ). Figure 4c reveals that deletion or mutation of the RGD motif completely abolished the apoptotic activity of big-h3 in CHO and H1229 cells.
Synthetic peptide encoding a putative RGD peptide released by big-h3 induces Apoptosis
To test whether exogenous RGD-containing peptides can directly induce apoptosis in CHO and H1229 cells, we used synthetic RGD peptides, one from big-h3 (ERGDEL) and one from FN (GRGDSP), which was Figure 4 Deletion of the RGD motif or mutation of RGD to RAE abolishes big-h3-mediated apoptosis. (a) Mammalian expression vectors encoding big-h3 lacking the C-terminal 44 amino acids that include RGD (pMycb-DC44) and big-h3 whose RGD motif has been mutated to RAE (pMycb-RAE). (b) Western blot analysis of big-h3 proteins expressed by transiently transfected CHO cells. Proteins were subjected to 10% polyacrylamide gel electrophoresis and immunoblotted with anti-myc-HRP antibody (a) or anti-big-h3 antibody (b). (c) DNA fragmentation in CHO and H1229 cells transfected with pMycb-WT, pMycb-DC44, or pMycb-RAE was assessed by agarose gel electrophoresis and ethidium bromide staining. The data shown are representative of three independent experiments used as a positive control peptide. Two negative control peptides, GRGESP and ERGEEL, were also employed. As shown in Figure 5 , GRGDSP and ERGDEL clearly induced apoptosis in both cell lines whereas GRGESP and ERGEEL did not.
Culture supernatant putatively containing RGD peptides released from big-h3 also induces apoptosis
To provide additional evidence to support the notion that RGD-containing peptides are released from cells expressing big-h3 and that these peptides can mediate apoptosis, we collected culture supernatants from cells overexpressing WT or RAE mutant big-h3 proteins. The supernatants were filtered through a membrane with 3 kDa molecular weight cutoff and the filtrate was added to CHO cells. The filtered culture supernatants from WT big-h3-expressing cells induced apoptosis, whereas the filtered supernatants of control cells and cells expressing the RAE mutant did not (Figure 6 ). These observations are consistent with the notion that C-terminal peptides containing RGD are released from big-h3 into the culture supernatant and they can induce apoptosis.
A fusion gene composed of the N-terminal part of FN and the C-terminal part of big-h3 is also subjected to C-terminal cleavage and its overexpression induces apoptosis
To examine whether the expression of the C-terminal sequence of big-h3 has a proapoptotic effect, we fused the C-terminal part of big-h3 (amino acids 517-683) with the N-terminal 1.13 kb fragment of the human FN gene and cloned the resulting gene into the mammalian expression vector pcDNA (Figure 7a) . CHO cells were then transfected. This fusion protein was not detected in the culture media by the anti-myc antibody but was observed in the monensin-treated cell layer (Figure 7b ). This indicates that the secreted fusion protein undergoes C-terminal cleavage like big-h3. We then tested whether expressing the fusion protein also induces apoptosis. As shown in Figure 7c , overexpression of WT big-h3 and the fusion protein induced apoptosis, whereas the empty vector did not. Thus, it is possible that the C-terminal peptides released by the fusion protein, like those from big-h3, have an apoptotic effect. (Figure 8a ). TGF-b also induced apoptosis of cells treated for 3 days. However, this apoptotic effect was significantly blocked by the presence of the anti-big-h3 antibody treatment but not by control IgG (Figure 8b ). This suggests that endogenously expressed big-h3 is involved in TGF-b-induced apoptosis.
Discussion
In this study, we demonstrated that big-h3 induces cells to undergo apoptosis through its RGD motif, which is released by the C-terminal cleavage upon secretion. It is known that many extracellular matrix proteins bear RGD sequences and other active cryptic sequences that are exposed as active soluble peptides. However, this usually occurs after the protein undergoes proteolytic fragmentation. As a TGF-b-induced cell adhesive molecule and being an extracellular matrix protein, big-h3 may be unique in that shortly after its synthesis it releases its RGD peptide by C-terminal processing rather than full degradation. We could not show directly that RGD-containing peptides are released from big-h3 in the culture supernatant as these peptides were too small for detection but the following observations indicate strongly that these peptides are generated and mediate apoptosis: (1) deletion or mutation of the RGD motif completely abolished the apoptotic activity of bigh3; (2) ERGDEL, a synthetic RGD peptide derived from big-h3, induced apoptosis whereas ERGEEL, a mutant peptide, did not; (3) molecules less than 3 kDa in size filtered from culture supernatants of cells overexpressing WT big-h3 induced apoptosis; (4) the It has generally been accepted that soluble RGDcontaining peptides prevent integrin-ligand interactions, resulting in blocking the signals needed for cell survival (Frisch and Francis, 1994) . The term 'anoikis' has been suggested to describe the apoptotic response to the absence of cell-matrix interactions mediated by soluble RGD peptides. Recently, Buckley et al. (1999) suggested that RGD peptides may activate the apoptotic cascade in a novel way, namely, by directly activating procaspase-3. Procaspase-3 has an RGD motif and a DDM sequence that resembles an RGD-binding site in integrin b-subunits and thus Buckley et al. theorized that RGD peptides trigger conformational changes, resulting in autoprocessing and the activation of procaspase-3. Supporting this possibility is a more recent report that an RGD peptide induces apoptosis in osteoblasts through caspase-3 (Perlot et al., 2002) . Thus, RGD peptides released from big-h3 may induce apoptosis by directly activating caspase-3 and/or by disrupting cellmatrix interactions.
Given that big-h3 is a secretory protein and that its RGD motif is released after secretion, it may be very difficult to accumulate a high enough local concentration of the RGD peptide to induce apoptosis in vivo. Such high local concentrations may occur only in certain environmental conditions, such as in tissues with few or no blood vessels. One such tissue is the cornea. Point mutations of the big-h3 gene are responsible for the 5q31-linked corneal dystrophies (Munier et al., 1997) . These diseases are characterized by the progressive accumulation in the cornea of deposits containing bigh3. This leads to epithelial cell degeneration and severe visual impairment. We have reported previously that five overexpressed mutant big-h3 proteins frequently found in 5q31-linked corneal dystrophies also undergo C-terminal cleavage (Kim et al., 2002) . Thus, the accumulation of big-h3 proteins in dystrophic corneas may increase the local concentration of RGD peptides, which then cause the degeneration of corneal epithelial cells.
The epiphysis of the long bones is also an avascular tissue. Interestingly, our preliminary experiments showed that the expression of big-h3 in the long bone is localized to the prehypertrophic and hypertrophic chondrocytes of the epiphysis. It is well known that hypertrophic chondrocytes undergo normal cell death processing during endochondral bone formation. Therefore, we suggest that RGD peptides released from bigh3 synthesized by prehypertrophic and hypertrophic chondrocytes may accumulate in the hypertrophic chondrocyte zone, thereby contributing to the apoptotic processing of hypertrophic chondrocytes during endochondral bone formation. RGD peptides released from big-h3 may also be important in the normal apoptosis of the skin epidermis, which also does not have vessels. The keratinocytes of the granular layer epidermis express big-h3 (LeBaron et al., 1995) and eventually undergo apoptosis. These putative in vivo big-h3 functions should be investigated, perhaps by constructing transgenic mice expressing big-h3 in a tissue-specific manner such as in the chondrocytes of the long bone epiphysis or in the keratinocytes in the epidermis.
The expression of big-h3 is highly induced by TGF-b treatment (Skonier et al., 1992 (Skonier et al., , 1994 . TGF-b has been reported to induce apoptotic cell death in many cell types, although the mechanisms that regulate this process are still poorly understood. Previous studies suggest that the production of reactive oxygen intermediates (Sa´nchez et al., 1996; Atfi et al., 1997) and the activation of caspase-family proteases (Chen and Chang, 1997; Inayat-Hussain et al., 1997) are involved in TGF-b-induced apoptosis. In addition, pRb (Choi et al., 1999) and Bcl-2 (Lafon et al., 1996) have been suggested to regulate TGF-b-induced apoptosis. More recently, it has been reported that TGF-b can generate apoptosis indirectly by inducing the expression of the connective tissue growth factor (Hishikawa et al., 1999) . Given that big-h3 is induced by TGF-b and has apoptotic activity, it is possible that big-h3 could also mediate TGF-b-induced apoptosis. Supporting this, we demonstrated in this study that TGF-b-induced apoptosis was reduced in the presence of the anti-big-h3 antibody. However, not every cell type appears to be sensitive to apoptosis mediated by the TGF-b and the big-h3 pathway. For example, fibroblasts, which constitutively produce high amounts of big-h3, are not sensitive to apoptosis mediated by TGF-b and big-h3 (data not shown) whereas CHO cells, which do not produce big-h3 even in the presence of TGF-b, are very sensitive to apoptosis mediated by TGF-b and big-h3. Based on experiments with other cell lines, we found that cell lines producing big-h3, endogenously in response to TGF-b are likely to be resistant to apoptosis mediated by TGF-b and big-h3, whereas cell lines that do not produce big-h3 even in the presence of TGF-b are likely to be sensitive (data not shown). Thus, sensitivity to apoptosis mediated by the TGF-b and the big-h3 pathway depends on the cell type.
Of all the cell lines we tested, H1299 cell is the only cell line that produces big-h3 and undergoes apoptosis in response to TGF-b. However, compared to most of the sensitive cell lines, H1229 requires higher TGF-b concentrations (5 vs 1 ng/ml) before it will produce bigh3 and undergo TGF-b-induced apoptosis. This may explain why the apoptotic response of H1299 cells to TGF-b is so marginal.
Although cells producing big-h3 in response to TGFb may themselves not be significantly affected by big-h3, neighboring cells may be more sensitive. TGF-b acts as a tumor suppressor by inhibiting cellular proliferation or by promoting cellular differentiation or apoptosis (Epstein, 2000) . Although the role of big-h3 in tumors has not been extensively studied, it has been reported to be downregulated in mesenchymal tumor cells (Schenker and Trueb, 1998) and rhabdomyosarcoma (Genini et al., 1996) . Our observations suggest that the TGFb-induced-big-h3 could be a mechanism mediating TGF-b-mediated tumor suppression and that it may act as a tumor suppressor.
In summary, we demonstrated that upon secretion, big-h3 produces RGD-containing peptides by C-terminal cleavage and that these peptides in turn induce apoptosis in several cell lines. big-h3 is unique as an extracellular matrix protein as it generates soluble RGD peptides directly from the newly synthesized protein. RGD peptides can affect a variety of biological and pathological processes. Thus, by mediating cell adhesion and by providing soluble RGD peptides, big-h3 may play important roles in regulating cell functions.
Materials and methods
DNA constructs
Full-length big-h3 cDNA was subcloned into pcDNA3.1/MycHis A (Invitrogen; Carlsbad, CA, USA) to generate the pMycb-WT construct. The big-h3 cDNAs lacking the Cterminal 30 and 44 amino acids were subcloned into the same vector, yielding the pMycb-DC30 and -DC44 constructs, respectively. The substitution mutant of pMycb-WT, where RGD was altered into RAE, was generated by a two-step PCR as described previously (Kim et al., 2000a) . The 1.13 kb Nterminal fragment of human FN corresponding to amino acids 1-100 was subcloned into the KpnI and SphI sites of pMycb-WT, thereby producing a fusion protein consisting of the FN N-terminal fragment fused to a C-terminal fragment of big-h3 corresponding to amino acids 518-683. This construct was denoted pMycb-FN.
Cell culture and transient transfection
CHO cells were cultured in a-MEM (Gibco BRL Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS) at 371C in 5% CO 2 . H1299 are human lung carcinoma cells and were cultured in RPMI 1640 medium (Gibco) with 10% FBS, 4.5 g/l glucose, 10 mm HEPES, and 1 mm sodium pyruvate. For transient transfections, plasmids were transfected into cells using the lipofectamine reagent (Gibco) according to the manufacturer's protocol. For the secretionblocking experiment, 0.5 mm monensin (Sigma) was added with the serum-free medium for 24 h. After incubation, the supernatants were lyophilized and analysed by immunoblot analysis using anti-big-h3 antiserum made as described previously (Kim et al., 2002) and anti-myc-HRP antibody (Invitrogen). To isolate molecules smaller than 3 kDa from cell supernatants, the supernatants were filtered with Centricon YM-3 (Amicon, Millipore Corporation, Bedford, MA, USA) for 2 h. The filtrates were added to new CHO cells. Cells were harvested after 20 h and DNA was extracted for the DNA fragmentation assay. Western blotting was performed as described previously (Kim et al., 2000b) .
DNA fragmentation assay
DNA samples were extracted by 30 min incubation at 01C in 0.1 ml lysis buffer (100 mm Tris-HCl, pH 7.5, 5 mm EDTA, 200 mm NaCl, 0.2% SDS, and 50 mg/ml freshly made proteinase K), recovered by isopropanol precipitation, resuspended in Tris-EDTA-RNase, analysed on 2% agarose gels, and visualized by ethidium bromide (1 mg/ml) staining.
Synthetic peptides
Synthetic peptides were synthesized on an automated multiple peptide synthesizer (PE/ABD 433, PE Corporation, Norwalk, CT, USA) using standard solid-phase procedures. Peptides were purified by reverse-phase high-performance liquid chromatography.
Assessment of apoptosis using propidium iodide
Cells collected after 2 days of incubation were washed twice with PBS, fixed in methanol : acetone (1 : 1) for 10 min, incubated for 1 h at 371C with propidium iodide (50 mg/ml) in the presence of RNase A (10 mg/ml), and mounted in antifade reagent (Sigma). Immunofluorescence was analysed by a laser scanning confocal microscope (Axiovert 100; Lens 3 Â 40/0.75; laser line 543, Carl Zeiss, Oberkochen, Germany). Pictures were taken on TMAX 100 film (Eastman Kodak Co., Rochester, NY, USA).
Assessment of apoptosis by ELISA
Cell apoptosis was assessed by the Cell Death Detection ELISA kit (Roche, Germany), which allows for the qualitative and quantitative in vitro determination of cytoplasmic histoneassociated DNA fragments. Briefly, cells collected after 3 days of incubation were washed and incubated in a lysis buffer for 30 min at room temperature. The lysates were then pelleted by centrifugation and the supernatant containing the cytoplasmic fraction was used for ELISA. The Student's t-test was used for statistical analysis and Po0.05 was considered to be statistically significant.
Abbreviations TGF-b, transforming growth factor-b; CHO cell, Chinese hamster ovary cell; FBS, fetal bovine serum.
